The Fabricated Products (FPR) business segment of H.C. Starck converts technology metal powders: molybdenum (Mo), niobium (Nb), tantalum (Ta) and tungsten (W) into customer-specific semi-finished and...
Article - 23 Aug 2006
The very slow progress in the treatment of severe diseases has led to the adoption of a multidisciplinary approach to the targeted delivery and release of drugs, underpinned by nanoscience and...
News - 2 Jun 2016
NANOBIOTIX has for the very first time developed a preliminary preclinical proof-of-concept (POC) with the main product NBTXR3 for its latest program in Immuno Oncology (IO). NANOBIOTIX is a late...
News - 6 Aug 2014
Oraya® Therapeutics, Inc. announced today that they have been awarded a $215,000 Small Business Technology Transfer Grant from the National Institutes of Health to investigate how Oraya Therapy, a...
News - 13 Jun 2014
On June 7, multidisciplinary researchers from across UC campuses came together at the Kingsgate Marriott Conference Center to develop new collaborations and research ideas in a unique...
News - 26 Oct 2010
Lumiphore Inc., a portfolio company of Nanostart
AG, has signed a global cooperation with Algeta ASA (Oslo Stock Exchange,
ticker: ALGETA), a leading company specializing in innovative...
News - 2 Nov 2009
An international team of physicists at Los Alamos National Laboratory has
succeeded in using intense laser light to accelerate protons to energies never
before achieved. Using this technique,...
News - 23 Aug 2007
Radioactive elements, or radionuclides, are well-established anticancer agents whose main limitation is that they kill healthy cells almost as easily as they do tumors. But because nanoparticles...
News - 15 Nov 2008
New piece of medical technology unveiled at the National
Physical Laboratory (NPL) today will help improve the success rates of radiotherapy
cancer treatments. The new clinical electron...
News - 2 Jun 2014
NANOBIOTIX, a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announced the successful completion of the first in human study of its lead NanoXray...